{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:33:59Z","timestamp":1760783639794},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1097\/cad.0b013e32835e64a0","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T13:20:08Z","timestamp":1359638408000},"page":"384-393","source":"Crossref","is-referenced-by-count":7,"title":["The new iodoacetamidobenzofuran derivative TR120 decreases STAT5 expression and induces antitumor effects in imatinib-sensitive and imatinib-resistant BCR\u2013ABL-expressing leukemia cells"],"prefix":"10.1097","volume":"24","author":[{"given":"Stefania","family":"Grimaudo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Meli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonietta","family":"Di Cristina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria R.","family":"Pipitone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romeo","family":"Romagnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Simoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Dieli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manlio","family":"Tolomeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210227","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0092-8674(84)90077-1","article-title":"Philadelphia chromosomal breakpoints are clustered within a limited region, BCR, on chromosome 22.","volume":"36","author":"Groffen","year":"1984","journal-title":"Cell"},{"key":"R2-7-20210227","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1084\/jem.189.9.1399","article-title":"The P190, P210, and P230 forms of the BCRABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.","volume":"189","author":"Li","year":"1999","journal-title":"J Exp Med"},{"key":"R3-7-20210227","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1182\/blood.V83.6.1575.1575","article-title":"Expression of BCR-ABL abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism.","volume":"83","author":"Sirard","year":"1994","journal-title":"Blood"},{"key":"R5-7-20210227","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood.V83.8.2038.2038","article-title":"Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia.","volume":"83","author":"Bedi","year":"1994","journal-title":"Blood"},{"key":"R7-7-20210227","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification.","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"R8-7-20210227","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrd2324","article-title":"Flying under the radar: the new wave of BCR-ABL inhibitors.","volume":"6","author":"Quintas-Cardama","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"R10-7-20210227","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.blre.2011.09.001","article-title":"Managing resistance in chronic myeloid leukemia.","volume":"25","author":"Roychowdhury","year":"2011","journal-title":"Blood Rev"},{"key":"R11-7-20210227","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1158\/0008-5472.CAN-06-4312","article-title":"BCR-tyrosine 177 plays an essential role in Ras and Akt activation and in human hematopoietic progenitor transformation in chronic myelogenous leukemia.","volume":"67","author":"Chu","year":"2007","journal-title":"Cancer Res"},{"key":"R13-7-20210227","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1182\/blood.V96.12.3915","article-title":"Bcl-2 expression restores the leukemogenic potential of a BCRABL mutant defective in transformation.","volume":"96","author":"Cirinna","year":"2000","journal-title":"Blood"},{"key":"R14-7-20210227","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.1038\/sj.onc.1204549","article-title":"Cooperative and redundant effects of STAT5 and Ras signaling in BCRABL transformed hematopoietic cells.","volume":"20","author":"Hoover","year":"2001","journal-title":"Oncogene"},{"key":"R15-7-20210227","doi-asserted-by":"crossref","first-page":"31704","DOI":"10.1074\/jbc.271.49.31704","article-title":"P210 and P190 (BCRABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members.","volume":"271","author":"Ilaria","year":"1996","journal-title":"J Biol Chem"},{"key":"R16-7-20210227","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1084\/jem.183.3.811","article-title":"Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by BCRABL.","volume":"183","author":"Carlesso","year":"1996","journal-title":"J Exp Med"},{"key":"R17-7-20210227","first-page":"1724","article-title":"BCRABL leads to the constitutive activation of STAT proteins, and shares an epitope with tyrosine phosphorylated stats.","volume":"10","author":"Frank","year":"1996","journal-title":"Leukemia"},{"key":"R18-7-20210227","first-page":"247","article-title":"Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia.","volume":"13","author":"Shuai","year":"1996","journal-title":"Oncogene"},{"key":"R19-7-20210227","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood.V96.6.2269","article-title":"BCRABL activates transcription of the Bcl-X gene through STAT5.","volume":"96","author":"Gesbert","year":"2000","journal-title":"Blood"},{"key":"R20-7-20210227","doi-asserted-by":"crossref","first-page":"8934","DOI":"10.1128\/MCB.23.24.8934-8945.2003","article-title":"STAT5 and Oct-1 form a stable complex that modulates cyclin D1 expression.","volume":"23","author":"Magne","year":"2003","journal-title":"Mol Cell Biol"},{"key":"R21-7-20210227","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/mcbr.2000.0231","article-title":"STAT5-dependent CyclinD1 and Bcl-xL expression in BCR-ABL-transformed cells.","volume":"3","author":"De Groot","year":"2000","journal-title":"Mol Cell Biol Res Commun"},{"key":"R24-7-20210227","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1073\/pnas.92.12.5287","article-title":"Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2.","volume":"92","author":"Sanchez-Garcia","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"R25-7-20210227","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/sj.onc.1201664","article-title":"Bcl-2-independent BCR-ABL-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL.","volume":"16","author":"Amarante-Mendes","year":"1998","journal-title":"Oncogene"},{"key":"R26-7-20210227","first-page":"4267","article-title":"BCL-2 antisense oligonucleotide genasense is active against imatinib-resistant BCR-ABL-positive cells.","volume":"9","author":"Tauchi","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R29-7-20210227","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/10428190802105090","article-title":"Anti-Bcl2 therapy in chronic myelogenous leukemia.","volume":"49","author":"Smith","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"R30-7-20210227","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2174\/187152009789124637","article-title":"Tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia.","volume":"9","author":"Tolomeo","year":"2009","journal-title":"Anticancer Agents Med Chem"},{"key":"R31-7-20210227","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1182\/blood-2005-10-4110","article-title":"STAT5 signaling is required for the efficient induction and maintenance of CML in mice.","volume":"107","author":"Ye","year":"2006","journal-title":"Blood"},{"key":"R32-7-20210227","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1084\/jem.189.8.1229","article-title":"Signal transducer and activator of transcription (STAT)5 activation by BCRABL is dependent on intact Src homology (SH)3 and SH2 domains of BCRABL and is required for leukemogenesis.","volume":"189","author":"Nieborowska-Skorska","year":"1999","journal-title":"J Exp Med"},{"key":"R34-7-20210227","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1038\/sj.leu.2402317","article-title":"Regulation of constitutive STAT5 phosphorylation in acute myeloid leukemia blasts.","volume":"15","author":"Birkenkamp","year":"2001","journal-title":"Leukemia"},{"key":"R36-7-20210227","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0301-472X(01)00787-1","article-title":"Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells.","volume":"30","author":"Spiekermann","year":"2002","journal-title":"Exp Hematol"},{"key":"R37-7-20210227","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood-2006-02-002030","article-title":"JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis.","volume":"108","author":"Lacout","year":"2006","journal-title":"Blood"},{"key":"R38-7-20210227","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1182\/blood-2005-12-4824","article-title":"Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model.","volume":"107","author":"Wernig","year":"2006","journal-title":"Blood"},{"key":"R39-7-20210227","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0955-0674(00)00199-X","article-title":"The STAT family in cytokine signaling.","volume":"13","author":"Ihle","year":"2001","journal-title":"Curr Opin Cell Biol"},{"key":"R40-7-20210227","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.bi.64.070195.003201","article-title":"Transcriptional responses to polypeptide ligands: the JAK-STAT pathway.","volume":"64","author":"Schindler","year":"1995","journal-title":"Annu Rev Biochem"},{"key":"R43-7-20210227","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity.","volume":"121","author":"Corbin","year":"2011","journal-title":"J Clin Invest"},{"key":"R44-7-20210227","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.biocel.2006.04.001","article-title":"A role for the cytoskeleton in STAT5 activation in MCF7 human breast cancer cells stimulated with EGF.","volume":"38","author":"Lopez-Perez","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"R45-7-20210227","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.bbrc.2004.10.081","article-title":"Stabilization, not polymerization, of microtubules inhibits the nuclear translocation of STATs in adipocytes.","volume":"325","author":"Gleason","year":"2004","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CAD.0b013e32835e64a0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:18:03Z","timestamp":1620947883000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001813-201304000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e32835e64a0","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}